Former Chief Financial Officer · Niagen Bioscience, Inc. (NAGE)

Kevin Farr

A named executive officer of Niagen Bioscience in every fiscal year CompBrief holds from FY2017 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$839,537

Salary $197,975Stock awards $150,729

FY2021: $626,429

3rd of 4 named executive officers at Niagen Bioscience by FY2022 total.

4 named officers on file for Niagen Bioscience, FY2022

Kevin Farr’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Niagen Bioscience’s whole pay program stands against its peers

  • Niagen Bioscience’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NAGE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Kevin Farr’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Kevin Farr compensation by year

Niagen Bioscience Summary Compensation Table · all 6 fiscal years held
In US dollars, as Niagen Bioscience reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022
Salary$60,000$300,000$306,577$320,884$309,000$197,975
Bonus$24,378$93,600$0$0$0$0
Stock awards$0$0$0$0$0$150,729
Option awards$3,040,183$0$210,450$209,217$215,808$215,697
Non-equity incentive$0$0$98,058$149,507$92,253$0
Pension and deferred compensation$0$0$0$0$0$0
All other$0$0$6,418$9,208$9,368$275,136
Total$3,124,561$393,600$621,503$688,816$626,429$839,537

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Niagen Bioscience, Inc. DEF 14A filed April 28, 2023, accession 0001628280-23-014158, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Niagen Bioscience, Inc. filed document, accession 0001628280-23-014158. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

$3.1M
$394K
$622K
$689K
$626K
$840K
FY17
FY18
FY19
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Niagen Bioscience’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Robert FriedChief Executive Officer$1,158,850
Brianna GerberChief Financial Officer$842,384
Kevin Farr · this pageFormer Chief Financial Officer$839,537
Frank Jaksch Jr.Former Executive Chairman, Current Chairman of the Board$482,354

The full Niagen Bioscience compensation record

free company brief

This page is one person within Niagen Bioscience's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Niagen Bioscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kevin Farr's compensation dossier · One-time report. No refunds.